Valion Bio VBIO
NASDAQ VBIO
$0.96 -0.16 (-14.63%)
At close: Oct 22, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Net Debt Issuances and Repayments (2021)

Updated

Analysis

Valion Bio (VBIO) Net Debt Issuances and Repayments (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -4.36 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -2.00 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -2.46 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -17.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 64.00 Mn
10 Valion Bio 130,630.24 -19.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 450,000.00
Jun 30, 2021 1.74 Mn
Mar 31, 2021 289,000.00
API Access

Valion Bio Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=VBIO&period=max&api_key=YOUR_API_KEY